Xiwei Ding
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
Papers in
- Surgery 14
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
-
- Gastric Cancer Management and Outcomes 6
- Gallbladder and Bile Duct Disorders 5
- Co-authors
- Junhua Wu (1 shared paper)Chunping Jiang (1 shared paper)Xiaoping Zou (18 shared papers)Shuling Huang (4 shared papers)Xiaoping Zou (6 shared papers)Qingguo Li (1 shared paper)Decai Yu (1 shared paper)S. Zhang (2 shared papers)
- Journals
- Surgical Endoscopy (4 papers)BMC Gastroenterology (3 papers)Pancreatology (2 papers)International Immunopharmacology (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiwei Ding
39 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 284
- Oncology 377
- Pulmonary and Respiratory Medicine 259
- Molecular Biology 502
- Surgery 221
Countries citing papers authored by Xiwei Ding
This map shows the geographic impact of Xiwei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwei Ding more than expected).
Fields of papers citing papers by Xiwei Ding
This network shows the impact of papers produced by Xiwei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwei Ding. The network helps show where Xiwei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiwei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 265 | |
| 2 | 2012 | 90 | |
| 3 | 2011 | 84 | |
| 4 | 2023 | 73 | |
| 5 | 2021 | 45 | |
| 6 | 2016 | 45 | |
| 7 | 2020 | 41 | |
| 8 | 2021 | 41 | |
| 9 | 2013 | 37 | |
| 10 | 2019 | 32 | |
| 11 | 2015 | 31 | |
| 12 | 2014 | 30 | |
| 13 | BRD4 degrader ARV-825 produces long-lasting loss of BRD4 protein and exhibits potent efficacy against cholangiocarcinoma cells. | 2019 | 30 |
| 14 | 2018 | 29 | |
| 15 | 2021 | 27 | |
| 16 | 2014 | 27 | |
| 17 | 2021 | 25 | |
| 18 | 2016 | 23 | |
| 19 | 2018 | 20 | |
| 20 | Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma. | 2019 | 17 |
About Xiwei Ding
Xiwei Ding is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer Mechanisms and Therapy (5 papers), Gallbladder and Bile Duct Disorders (5 papers), Cancer-related molecular mechanisms research (4 papers), Drug Transport and Resistance Mechanisms (3 papers), MicroRNA in disease regulation (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). The work is most often cited by research in Cancer Research (284 citations), Oncology (377 citations), Pulmonary and Respiratory Medicine (259 citations), Molecular Biology (502 citations) and Surgery (221 citations). Xiwei Ding has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Junhua Wu, Chunping Jiang, Xiaoping Zou, Shuling Huang, Xiaoping Zou, Qingguo Li, Decai Yu, S. Zhang, Ying Lv and Min Chen. Their work appears in journals such as Surgical Endoscopy, BMC Gastroenterology, Pancreatology, International Immunopharmacology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.